Considerations when using breast cancer risk models for women with negative BRCA1/BRCA2 mutation results.
暂无分享,去创建一个
A. Whittemore | W. Chung | G. Giles | J. Hopper | E. John | M. Southey | S. Buys | R. Milne | I. Andrulis | J. Knight | G. Glendon | G. Dite | M. Friedlander | M. Daly | D. Goldgar | M. Terry | R. MacInnis | Y. Liao | R. Buchsbaum | K. Phillips | S. McLachlan | N. Zeinomar | P. Weideman | S. Nesci | Nicole M Leoce | Nicole M. Leoce | Stephanie Nesci